Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
dabrafenib Dabrafenib Lymphoma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Lung Cancer Malignant Melanoma Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
dacarbazine Dacarbazine Lymphoma Soft Tissue Sarcomas Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Dacogen Malignant Melanoma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
dacomitinib Dacomitinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
dactinomycin Soft Tissue Sarcomas Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Testicular Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
daratumumab Daratumumab Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Multiple Myeloma Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
daratumumab and hyaluronidase Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
daratumumab and Hyaluronidase-fihj
Darzalex
dasatinib Dasatinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Leukemia
daunorubicin Daunorubicin Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Leukemia Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
daunorubicin and cytarabine liposome Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Daunorubicin and Cytarabine Liposome Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
daunorubicin liposome Daunorubicin Liposome Kaposi's Sarcoma
DaunoXome
DCC-2618
decitabine Decitabine Myelodysplastic Syndrome Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Leukemia Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
decitabine/cedazuridine Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
decitabine-cedazuridine
degarelix Prostate Cancer Degarelix
Depsipeptide
dexamethasone Common Regimens for Chemotherapy-Induced Nausea and Vomiting Lung Cancer Malignant Mesothelioma Ovarian Cancer (Epithelial) Waldenström's Macroglobulinemia Colorectal Cancer Leukemia Lymphoma Multiple Myeloma Prostate Cancer
DHAP
DIC Dabrafenib Dacarbazine
docetaxel
dostarlimab
Doxil Doxorubicin liposome Lymphoma
doxorubicin liposome Breast Cancer Endometrial Cancer Multiple Myeloma Soft Tissue Sarcomas Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Doxorubicin liposome Kaposi's Sarcoma Ovarian Cancer (Epithelial) Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
doxorubicin
dronabinol Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting: Common Regimens for Chemotherapy-Induced Nausea and Vomiting
DTIC-dome
durvalumab Lung Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Durvalumab Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function